Skip to main content

Table 2 Diagnostic delays and out-of-pocket expenditure reported by survey participants (N=100)

From: The impact of the COVID-19 pandemic on patients’ experiences obtaining a tuberculosis diagnosis in Peru: a mixed-methods study

 

Period 1* median (IQR)

Period 2* median (IQR)

Wilcoxon rank sum p-value for comparison of period 1 vs 2

Total weeks of diagnostic delay

15 (5–26)

6 (3–14)

0.027

Weeks of delay before contact with health system

4 (0–10)

4 (0–8)

0.497

Weeks of delay after contact with health system

4 (0–10)

2 (0–6)

0.165

Number of visits to health system

2 (2–4)

3 (2–5)

0.029

Amount spent on transport, visits, and medications (USD)

80 (13–222)

22 (4–61)

0.009

  1. *Period 1 (November 2020–April 2021) was during the first year of the COVID-19 pandemic in Peru; Period 2 (October 2021–February 2022) was after most of the country had been vaccinated